# Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus

> **NCT01838083** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 50 (actual)

## Conditions studied

- Type1 Diabetes

## Interventions

- **DRUG:** Insulin glargine new formulation HOE901

## Key facts

- **NCT ID:** NCT01838083
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2013-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01838083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01838083, "Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01838083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*